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Abstract
Background: Food allergy may affect the gastrointestinal tract and eosinophilia is often associated with allergic
gastrointestinal disorders. Allergy to peanuts is a life-threatening condition and effective and safe treatments still need to be
developed. The present study aimed to evaluate the effects of sustained oral exposure to peanuts on the esophageal and
jejunal mucosa in sensitized mice. We also evaluated the effects of desensitization with epicutaneous immunotherapy (EPIT)
on these processes.
Methods: Mice were sensitized by gavages with whole peanut protein extract (PPE) given with cholera toxin. Sensitized
mice were subsequently exposed to peanuts via a specific regimen and were then analysed for eosinophilia in the
esophagus and gut. We also assessed mRNA expression in the esophagus, antibody levels, and peripheral T-cell response.
The effects of EPIT were tested when intercalated with sensitization and sustained oral peanut exposure.
Results: Sustained oral exposure to peanuts in sensitized mice led to severe esophageal eosinophilia and intestinal villus
sub-atrophia, i.e. significantly increased influx of eosinophils into the esophageal mucosa (136 eosinophils/mm
2) and
reduced villus/crypt ratios (1.660.15). In the sera, specific IgE levels significantly increased as did secretion of Th2 cytokines
by peanut-reactivated splenocytes. EPIT of sensitized mice significantly reduced Th2 immunological response (IgE response
and splenocyte secretion of Th2 cytokines) as well as esophageal eosinophilia (50 eosinophils/mm
2,p ,0.05), mRNA
expression of Th2 cytokines in tissue - eotaxin (p,0.05), IL-5 (p,0.05), and IL-13 (p,0.05) -, GATA-3 (p,0.05), and intestinal
villus sub-atrophia (2.360.15). EPIT also increased specific IgG2a (p,0.05) and mRNA expression of Foxp3 (p,0.05) in the
esophageal mucosa.
Conclusions: Gastro-intestinal lesions induced by sustained oral exposure in sensitized mice are efficaciously treated by
allergen specific EPIT.
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Introduction
Digestive lesions such as eosinophilic gastrointestinal disorders
(EGID) and food-induced enteropathy, with more or less
pronounced villus atrophy (VA), are usually related to food-
allergen exposure [1–3]. Treatment consists of elimination of the
offending food(s) [2–4], using more or less elemental formula —
often poorly tolerated— and local or systemic steroids, [5]. The
last is an effective treatment but has side effects including
reduction of height gain in children and triggering of esophageal
candidiasis [6]. Discontinuation of any of the current treatment
regimens can result in relapse [7], indicating a need for alternative
treatments.
Epicutaneous immunotherapy (EPIT) has gained increasing
evidence for safety and efficacy in the treatment of allergy in
animals [8,9] and humans [10,11]. Until now, its potential role in
treating eosinophilic esophagitis (EoE) and allergic enteropathy
has not been investigated. The first clinical trials of oral specific
immunotherapy had promising results for food allergy but
revealed EoE as a potential side-effect [12,13].
In mice, EPIT depressed the eosinophilic infiltration of the lung
after nasal challenge through a Treg-dependant mechanism of
down-regulating the Th2 biased immune response [8,9]. However,
the effect of EPIT on the esophageal and intestinal mucosa after
sustained oral exposure to allergens in sensitized mice has never
been described.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31967The present study thus aimed to evaluate the effects of sustained
oral exposure to peanuts on the esophageal and jejunal mucosa in
sensitized mice that were desensitized with EPIT. For this purpose,
we developed a murine model of sustained oral exposure to peanuts
insensitized mice,resultinginesophagealeosinophiliaandintestinal
villus sub-atrophia. We believe that this model is efficaciously
mimicking homologous human conditions, and can be proposed to
test innovative interventions in the field of specific immunotherapy.
Mice were submitted to an elimination diet of the offending food
followed by sustained oralexposure to allergens. We took advantage
of this peculiar configuration to analyze the mucosal reaction when
the sustained food challenge is preceded by EPIT.
Materials and Methods
Animals
Three-week-old female BALB/c mice (Charles Rivers, Lyon,
France) were purchased and housed under standard animal
husbandry conditions. All experiments were performed according
to the European Community rules on animal care, with
permission 92–305 from the French Veterinary Services and with
a positive evaluation from the Ethical Committee of Paris
Descartes University (Paris, France; P2.LM.130.10). Mice were
acclimated for 1 week before immunization.
Food sensitization and sustained oral peanut exposure
(figure 1)
Set up of the model (figure 1A). To evaluate the lesions
triggered by a sustained oral exposure to peanuts, 40 mice were
first sensitized to peanut proteins (PPE) by means of 6 intra-gastric
gavages (D1, D7, D13, D19, D25, D32), as previously described
[9], with 1 mg of PPE mixed with 10 mg of Cholera Toxin (CT –
Servibio, USA). Mice were then maintained for 8 weeks on a
peanut-free regimen without any treatment. After that, peanuts
were reintroduced into their regimen (sustained oral exposure to
peanuts). This consisted of exclusive feeding with peanut seeds
instead of standard mouse food for 4 consecutive days. As all mice
(including naı ¨ve mice) exhibited diarrhea may be due to the highly
fat enriched feeding, animals then received peanut seeds mixed
into standard food for the 6 following days, and daily intra-gastric
administration of a solution containing 10 mg of peanut protein
for the last 3 days of this second phase. At different time points
during peanut regimen (before, D2, D4, D7, and D10), 8
sensitized mice were sacrificed after deep anesthesia with an
intra-peritoneal injection of 30 mg/kg sodium pentobarbital and
samples were taken to examine the histology of the esophagus and
jejunum, the mRNA expression of cytokines in the esophagus
mucosa, and the cytokines secreted by reactivated splenocytes.
Blood samples were also collected from retro-orbital plexus under
anesthesia with isoflurane (Isoflurane Belamont, Nicholas Piramal
India) at the end of the sensitization period (D44) and just before
the beginning of the sustained oral exposure to peanuts (D89).
Forty naive mice (568 mice) serving as controls were also
subjected to the same procedures.
Intercalation of epicutaneous immunotherapy (EPIT)
(figure 1B). As a second investigation, the effects of sustained
oral exposure to peanuts using the above protocol were evaluated
following an8-weekperiod of desensitization by EPIT. For this study,
10 micewere sensitized to peanut proteinsand treated withEPIT and
compared with sensitized and non-treated animals (Sham). The
animals then underwent sustained oral exposure to peanuts. Ten
n a i v em i c es e r v i n ga sc o n t r o l sr e c e i v e dt h es a m ep r o c e d u r e s .T h ed a y
after the last challenge, mice were anesthetized and sacrificed and
sample studies were performed as described above.
Analysis of esophageal eosinophilia and jejunum villus
atrophy
Esophagus and jejunum were collected and fixed in 4% neutral-
buffered formalin, embedded in paraffin wax, sliced transversally
into 5-mm thick sections, and fixed onto positive-charge slides.
Sections were then stained using a routine hematoxylin-eosin-
safranine staining method (HES).
Three sections of esophagus and 6 sections of jejunum were
analyzed in a double-blind manner. All lesions were reported by a
skilled ECVP-certified pathologist. Semi-quantitative evaluations
of the mucosal thickness of the esophagus reflecting acanthosis and
chorionic inflammation in the esophagus and jejunum were also
performed. Thickness scores were as follows: 0, no more than 3
layers of acanthocytes; 1, from 4 layers of acanthocytes; and 2,
more than 6 layers of acanthocytes with diffuse hyperkeratosis.
Inflammation was scored was as follows: 0, less than 2 eosinophils
per high-powered field; 1, diffuse infiltration by scattered
eosinophils; 2, presence of foci of more than 20 eosinophils; and
3, presence of foci of more than 100 eosinophils.
Image analysis was performed on esophagus and jejunum
sections using a digital camera (Nikon DXM 1200, Champigny,
France) combined with image-analysis software (Nikon Imaging
Software) used only for photo acquisition and data storing. Six
high-powered fields were randomly selected around the esopha-
geal lumen and quantification of thickness was performed from the
lumen to the basement membrane of each esophagus. Eosinophils,
characterized by their pink-red granulation and their horseshoe-
shaped bilobed nucleus, were then counted by the pathologist, and
results were expressed as number of eosinophils per mm
2. Intra-
observer agreement was tested by reproducing this measure 3
times on the same sample and the coefficient of reproducibility was
determined to be 93.7%. In addition, 6 intermediate-powered
fields were randomly selected around the jejuna lumen, and the
ratio of villous height to crypt depth was evaluated. Intraobserver
agreement was tested by triplicate measures of eachsample.
Reproducibility was 89.9%.
Epicutaneous immunotherapy (EPIT)
EPIT was performed using the EDS ViaskinH (DBV Technol-
ogies, Paris France) [14] and the treatment protocol which has been
previously described [9]. Briefly, mice were anaesthetized intraper-
itoneally with 100 mg/kg body weight of ketamine (Imalgen1000H,
Merial, Lyon, France) and 10 mg/kg body weight xylazine
(RompunH, Bayer, Puteaux, France), and were then shaved with
an electric clipper and depilatory cream without corticoid (VeetH,
Massy, France). Twenty-four hours later, after total recovery of the
skin, mice were anaesthetized and EDS with 100 mg of PPE,
provided by Greer Laboratories (Lenoir, USA), were applied once a
week for 48 h to the back of mice from which hair had been
removed. This technique for the preparation of the skin does not
modifythebarrierpropertiesofthe skin.Thiswasdemonstratedina
preliminary experiment where transepithelial water loss (TEWL)
after skin preparation was measured and compared with the values
obtained in hairless mice (6.4561.22 vs. 6.6361.49 g/h/m
2
repectively, ns). For sham immunotherapy, the EDS was left empty,
and no treatment was administered to the naive group.
Reverse-transcription quantitative PCR (RT-qPCR)
Total RNA from esophageal sections was extracted using the
RNeasy Mini Kit (Qiagen, Courtaboeuf, France) in accordance
with the manufacturer’s instructions. The concentration of RNA
was determined and complementary DNA (cDNA) was synthe-
tized by reverse transcription reaction (SuperScript II RNase H
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PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31967reverse transcription reagents, Invitrogen, Cergy-Pontoise, France)
containing 500 ng of RNA from the experimental sample.
Quantitative PCR analyses in real time were performed with the
LightCyclerH 480 Real-Time PCR System using SYBR-green
fluorescence (Roche Diagnostic, Mannheim, Germany) for
quantification. The thermal-cycling conditions were: 95uC for
5 min and then 45 cycles at 95uC (5 s), 55uC (5 s.), and 72uC
(10 s.). This was followed by the standard denaturation curve. The
murine primer sequences are shown in Table 1. These were
designed with the OLIGO6 software package using the nucleotide
sequences from the GenBank database. Each PCR reaction
contained LightCyclerH 480 SYBR Green I Master Mix (Roche
Diagnostic), the gene specific primers, and the cDNA derived from
the experimental RNA sample. The threshold for positivity was
determined based on the negative controls. Results were presented
as mRNA expression in the naive, EPIT, and Sham animals.
Target gene expression was calculated relative to the expression of
b-actin and SDHA in each experimental sample, using the DCq
method and the results were depicted as arbitrary units. In a
preliminary study, we validated that b-actin and SDHA are the 2
most stable housekeeping genes (HKG) in our model and could be
used together to normalize mRNA expression data. Each set of
quantitative PCR reactions were also ran with negative controls
without RNA and without RT.
Measurement of blood-specific IgE, IgG1, and IgG2a
Blood was collected after sensitization (week 6), and every 2
weeks during immunotherapy (i.e. weeks 8, 10, 12, and 14) and
plasma samples were prepared in tubes containing EDTA.
Specific antibodies were quantified using a quantitative ELISA
developed in-house according to the 2001 FDA guidelines as
previously described [8]. Briefly, plasma samples were incubated
in microtiter plates previously coated with PPE. The presence of
specific IgE (sIgE), IgG1 (sIgG1), and IgG2a (sIgG2a) was detected
by the addition of an anti-mouse IgE, IgG1 or IgG2a antibody
labeled with alkaline phosphatase (Serotec, Oxford, England). The
reagent, pNPP (Sigma, France) was used as an enzyme substrate
and the optical density was measured at 405 nm. Specific IgE,
IgG1, and IgG2a were quantified by comparison with concentra-
tion-response curves obtained with a total IgE, IgG1 or IgG2a
assay performed under identical conditions using a solid phase
coated with an anti-mouse IgE, IgG1 or IgG2a antibody (Serotec,
Oxford, England) -which is complementary to tracer- instead of
peanut proteins. Mouse immunoglobulin standards were obtained
from Serotec (Oxford, England).
As the high level of IgG might lead to underestimation of the
sIgE level, the ELISA method has been confirmed by a reverse
enzyme allergo-sorbent assay (EAST).
Figure 1. Study design for induction of eosinophilic esophagatis and enteropathy and for the effect of EPIT on the induction of
digestive lesions. (A) Fourty mice were sensitized to peanut proteins in the first phase. Then a resting period with no treatment and no peanut
administration was applied. After that, a peanut regimen for 10 days was given to sensitized and naı ¨ve mice (n=40). Mice were then sacrificed to
analyze esophagus and jejunum samples by histology and RT-qPCR. (B) Twenty mice were sensitized to peanut proteins in the first phase.
Epicutaneous immunotherapy was conducted for 8 weeks in 1a ` sensitized mice (EPIT) and 10 other sensitized mice received a Sham treatment
(Sham). After a sustained oral challenge, mice were sacrificed to analyze esophagus and jejunum samples by histology and RT-qPCR. Blood samples
were taken every 2 weeks to measure specific immunoglobulins (IgE, IgG1, IgG2a).
doi:10.1371/journal.pone.0031967.g001
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After 8 weeks of treatment, spleens were teased into a single-cell
suspension and washed three times in RPMI-1640 (Gibco,
France). Cells were counted and adjusted to a culture density of
4610
6 cells/ml and cell suspensions of 500 ml were placed into
each well of a 24-well microtitre plate (Nunc) together with 500 ml
medium or PPE (100 mg/ml). After 72 h, the supernatants were
harvested and analysed for the presence of cytokines (IL-4, IL-5,
IL-13, IL-10, IFN-c) using the BioPlex cytokine Assay (BioRad,
Marnes-la-Coquette, France) in accordance with the manufactur-
er’s instructions. TGF-b was analysed using ELISA kit (R&D
system, Minneapolis, USA).
Statistical analysis
The GraphPad Prism Software 5.0 (San Diego, CA, USA) was
used for statistical analysis (n=10 mice per group). Results are
expressed as mean 6 standard deviation (SD). Antibody and
cytokine responses were analyzed using analysis of variance
(ANOVA) and Tukey’s test for intergroup comparisons. For
histological analyses, statistical significance comparing different
sets of mice was determined by Student’s t test.
Results
The model of peanut-induced allergic esophago-gastro-
enteropathy
The kinetics of digestive, esophageal and jejunal, lesions
triggered by the sustained oral exposure to peanuts were easily
monitored as indicated in the Methods section (Figure 2).
To a clinical point of view, all mice (sensitized or not) had
seborrhea and diarrhea without any differences between groups.
No weight loss nor significant changes in activity/nutritional status
nor drop of rectal temperature were observed.
In peanut-sensitized mice, only 10 days after the sustained oral
exposure to peanuts, the esophagus showed massive infiltration
with inflammatory cells, particularly eosinophils, in the lamina
propria around the vascular plexus or more diffusely in the most
severe cases (Figures 2A and 2B). The eosinophil infiltration
increased from nil at day 0 (before sustained oral exposure to
peanuts) to 110.5 eosinophils/mm
2 after 10 days; this was
significantly higher than in naive mice (22.6 eosinophils/mm
2,
p,0.05) (Figure 2C). Eosinophil infiltration was accompanied by
an increased esophageal expression of IL-5, IL-13, and eotaxin
mRNA (Figures 2D, 2E, and 2F). The significant induction of IL-5
for sensitized mice appeared after 10 days of sustained oral
exposure to peanuts (2.8 vs 0.89 for naı ¨ve, p,0.01) (Figure 2D).
From 2 days of peanut regimen to the end of peanut regimen,
eotaxin and IL-13 mRNA were significantly over-expressed in
sensitized mice compared with naive mice.
In the jejunum, sustained oral exposure to peanuts was
associated with obvious jejunal lesions (Figure 2G), with deep
necrotic debris in the crypts of Lieberkuhn. Compared with naive
mice, the recruitment of inflammatory cells in the lamina propria
consisted mostly of eosinophils in the sensitized mice. In the most
severe cases, large groups of clustered eosinophils reached into the
submucosa, some of them migrating across the epithelium. From
the second day to the end, the sustained oral exposure to peanuts
also induced a degree of villous sub-atrophy in the sensitized mice
with an overall decrease in villous height and increase in crypt
depth, which significantly reduced the villus/crypt ratio compared
with naive mice (Figure 2H).
sIgE, sIgG1, and sIgG2a levels were monitored after sensitiza-
tion and every 2 weeks during the 8 weeks of no treatment
combined with peanut elimination (figure 3). After sensitization,
sIgE increased in all sensitized mice (figure 3A), as previously
observed [8,9]. During the 8 weeks of peanut food exclusion,
specific IgE as well as specific IgG2a did not change from D44 to
D89 (Figure 3A). In response to PPE stimulation, splenocytes in
culture showed markedly increased levels of the Th2 cytokines IL-
4, IL-5, and IL-13 after sensitization and 8-week-peanut food
exclusion as well as during sustained oral exposure to peanuts
compared with naı ¨ve mice (figures 3B, 3C, and 3D). The Th1
cytokine IFN-c also significantly increased after sensitization
during sustained oral exposure to peanuts (p,0.001 or p,0.01,
figure 3E). It was verified that the cytokine profiles of the same
cells cultured in the presence or absence of concanavalin A did not
differ between groups (data not shown). No secretion was seen
when cells from naive and sensitized mice were cultured in
medium alone.
Effects of sustained oral exposure to peanuts in
sensitized mice treated with EPIT
In this model of esophago-gastro-enteropathy, EPIT was
intercalated, 7 days after sensitization and 7 days before sustained
oral exposure to peanut, allowing comparison of all groups (naive
mice, sham, and EPIT treatments). In EPIT mice (Figure 4), the
tissue sections following sustained peanut food exposure exhibited
a lower cell infiltration in the lamina propria and epithelium than
in Sham, with an aspect similar to naive mice. Semi quantitative
evaluation of inflammation was lower in EPIT than Sham (0.33 vs
1.22, p,0.05; Figure 4G) as it was acanthosis (0.25 vs 1.22,
p,0.01; Figure 4H). The thickness of the epithelium was also
significantly decreased in EPIT (data not shown). Moreover,
eosinophilic infiltration of the mucosa was clearly smaller in EPIT
than in Sham, (49.6 vs 136.2 eosinophils/mm
2,p ,0.05 vs sham).
At the molecular level, EPIT prevented induction of Th2 cytokines
(Figures 4J, 4K, and 4L), as indicated by significantly lower
Table 1. Primer sequences used in quantitative real time-PCR
assays.
Primers Sequences
Predicted
fragment
length
b-actine Sense GTGGCATCCATGAAACTACAT
Antisense GGCATAGAGGTCTTTACGG
73 bp
SDHA Sense CTTGAATGAGGCTGACTGTG
Antisense ATCACATAAGCTGGTCCTGT
87 bp
TGF-b Sense TGACGTCACTGGGAGTTGTACGG
Antisense GGTTCATGTCATGGATGGTGC
170 bp
IFN-c Sense TCAAGTGGCATAGATGTGGAAGAA
Antisense TGGCTCTGCAGGATTTTCATG
93 bp
IL-4 Sense CATGGGAAAACTCCATGCTT
Antisense ATGAATCCAGGCATCGAAAA
87 bp
IL-5 Sense GCTGGCCTCAAACTGGTAATGTA
Antisense GGCAATGGTGCATGTCTGTAACCTC
100 bp
IL-13 Sense AGACCAGACTCCCCTGTGCA
Antisense TGGGTCCTGTAGATGGCATTG
125 bp
IL-10 Sense CCAGAGCCACATGCTCCTAGA
Antisense AGCTGGTCCTTTGTTTGAAAGAA
78 bp
CCL-11
(eotaxin)
Sense AAACAACCTCCTCTCTTGACACTAA
Antisense GCGACTGGTGCTGATATTCC
114 bp
Foxp3 Sense CCCGGAGAGGCAGAGGACACTCAAT
Antisense AGGCTCAGGTTGTGGCGGATG
114 bp
doi:10.1371/journal.pone.0031967.t001
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IL-13 (p,0.05). The mRNA levels following EPIT were similar to
those in naive mice. The expression of Foxp3 was significantly
higher after EPIT compared with the Sham and naive groups
(p,0.05) (figure 4M). Moreover, EPIT induced a significant
decrease of the Th2 transcription factor GATA-3 compared with
the Sham-treated group (p,0.05) (figure 4N) and had no effect on
the Th1 transcription factor Tbet (Figure 4O). No significant
changes were observed for mRNA levels of IL-4, IL-10 and IFN-c
(data not shown).
After EPIT, the tissue sections of the jejunum obtained following
the peanut exclusive diet showed a sub-mucosal eosinophilic
infiltration that was reduced compared with Sham (Figures 5A–
5F). EPIT also prevented modification of the villous height/crypt
depth ratio observed with sham (Figure 5G). Indeed, the decrease in
height/crypt ratio was abolished (2.360.18, p,0.01 vs Sham), and
the ratio was similar to that observed in naive mice.
Specific antibodies (sIgE, sIgG1, and sIgG2a) were monitored
after sensitization and every 2 weeks during the 8 weeks of
epicutaneous treatment (Figures 6A, 6B and 6C). During the 8
weeks of EPIT, sIgE slowly decreased until there was a significant
difference between EPIT and Sham (p,0.05). Similarly, sIgG2a
significantly increased in EPIT compared with Sham-treated mice
(p,0.05) from the 2
nd week until the end of the immunotherapy
(Figure 6B). No changes were observed in Sham-treated mice.
Specific IgG1 were not modified after the 8 weeks of EPIT (data
not shown). The sIgG1/sIgG2a ratio (Figure 6C) significantly
increased during the 8 weeks of immunotherapy in EPIT-treated
mice, with no modification in Sham-treated mice, as previously
reported [8,9]. Moreover, splenocytes from EPIT-treated mice
produced significantly less IL-5 and IL-13 (p,0.05), and IL-10
(p,0.01) compared with the Sham group. The Th1 cytokine IFN-
c was not influenced by PPE treatment and the same applied to
TGF-b secreted by Treg cells (data not shown).
Discussion
This is the first study to assess the efficacy of EPIT on the
esophago-gastro-enteropathy triggered by a sustained oral expo-
sure to peanuts. The effects of food on the esophagus [15–19] and
jejunum [20] in sensitized mice have been already evaluated in
models of eosinophilic esophagitis published by Mishra et al. [15–
17], using fungus or house dust mite sensitization followed by nasal
or oral challenge. Mice sensitized then challenged to allergens
exhibited severe mucosal injury with chorionic infiltration by
inflammatory cells including eosinophils as well as acanthosis in
the esophageal mucosa. These authors did not use peanut
allergens neither orally exposed sensitized animals. In contrast,
we maintained in a peanut-free diet previously sensitized animals
in order to more closely mimic the elimination diet which is
prescribed to EGID patients [21]. Along this line, in our model the
allergen was subsequently reintroduced, to further reproduce these
clinical recommendations [12]. Sustained oral exposures to
peanuts allowed us to obtain the first model of combined
esophageal and jejunal injuries. The esophagus epithelium was
thickened, mainly due to hyperplasia of the acanthocytic layer.
Mucosal RT-qPCR showed significantly higher mRNA levels of
eotaxin, IL-5, and IL-13 which are involved in the pathogenesis of
EoE [18,22,23]. In particular, IL-5 and eotaxin are involved in
chemotaxis of eosinophils whereas IL-13 interacts with epithelial-
differentiation cluster genes which determine tissue remodeling in
human EoE [23,24]. These results, in parallel with the
measurement of cytokines in the supernatant of in vitro reactivated
spleen cells after provocation by PPE, are consistent with the data
summarized by Rothenberg et al. [25] and recently published by
his coworkers [23,24,26], which confirmed the increase of these
cytokines during human EoE. In our analysis of the kinetics of
induction of digestive lesions by peanut regimen, histological data
and IL-5 mRNA expression showed that digestive lesions were the
most marked after 10 days of sustained oral peanut exposure. In
the jejunum, sustained oral exposure to peanuts in sensitized mice
induced a villus sub-atrophy combined with a high recruitment of
eosinophils in the lamina propria. These digestive lesions closely
resemble those described in EGID, [2]. They also resemble the
lesions seen in food-induced malabsorption syndrome [27], which
seems to become less frequent. The method allows an exact
quantification of digestive lesions, thus facilitating the evaluation of
any kind of treatment. Compared to the studies published by
Mishra et al. [15–17,19], our mice had higher levels of eosinophil
infiltrations likely due to peanut diet re-challenge (Mishra et al.
used saline) and the conventional housing used (versus SPF
conditions).
Despite the remarkable severity of lesions induced by the peanut
regimen, they were almost fully prevented by EPIT, which seem to
render animals almost insensitive to sustained oral peanut
exposure. These results agree with our previous reports on EPIT
efficacy on airway hyper-responsiveness in mice sensitized to
peanut proteins and treated with EPIT before aerosol challenge
[9], invasive and non invasive measurements of airway hyper-
responsiveness showed that EPIT-treated mice were comparable
to naive mice, with values lower than in non-treated animals [9].
In the present study, all parameters linked to esophageal injuries,
i.e. chorionic inflammation, acanthosis, and eosinophilic infiltra-
tion, and to villus sub-atrophy, were significantly reduced by EPIT
to the levels observed in naive mice. Further confirmation is given
by the decrease of mRNA expression for Th2 cytokines as IL-5,
IL-13, and a chemoattractant of eosinophils, eotaxin, all involved
in the pathogenesis of EoE. The decrease of inflammation in the
esophagus might be a consequence of the downregulation of Th2
cytokines by regulatory mechanisms: the increased expression of
Foxp3 mRNA in esophageal mucosa might downregulate the
expression of GATA-3 mRNA, a Th2 transcription factor. On the
other hand, EPIT had no effect on the expression of Tbet mRNA.
Similar effects were obtained in the jejunum with a complete
protection of the villus. A preliminary approach to identify the
mechanism was made. In a first experiment of depletion of
CD4
+CD25
+ regulatory T cells in sensitized mice during EPIT,
the high infiltration of eosinophils after the sustained peanut oral
exposure was maintained. Moreover, the protective effect of EPIT
Figure 2. Establisment of the model of peanut-induced allergic esophagus-gastro-enteropathy by histological and RT-qPCR
analyses. Microscopic analysis of eosinophils at 1006in the esophagus of naive (A) and sensitized (B) mice. Most eosinophils (arrows) are located in
the lamina propia, submucosa, and epithelial layer of the sensitized group. (C) Measurement of eosinophil infiltration in the esophagus at 406; the
results are expressed as number of eosinophils per mm
2 (means 6 SD). Cytokine mRNA from esophagus segments was assayed by RT-qPCR. The
relative levels of gene expression were calculated by reference to the mRNA levels of SDHA and b-actin in each sample. (D) IL-5, (E) eotaxin, (F) IL-13.
Jejunum segments collected and analyzed by microscopy after HES coloration (640); inflammatory infiltration, particularly of eosinophils is shown in
(G). Measurement of the ratio of villous height to crypt depth for each group of 10 mice at 106. Results are expressed as means 6 SD (H). N: naı ¨ve
mice, S: sensitized mice.* p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0031967.g002
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31967Figure 3. Systemic response induced in mice after oral sensitization analyzed in plasma and spleens. (A) Quantity of specific IgE and
IgG2a expressed in mg.ml
21 for each group. Data are expressed as means 6 SD for each group mice, D44 after oral sensitization, D89 after the 8-week
resting period of peanut free diet. (B–E) Measurement of Th2 cytokine levels (IL-4, IL-5, IL-13) and IFN-c secretion by splenocytes collected from each
group of mice (EPIT, Sham, and naı ¨ve) immediately after sacrifice. Splenocytes were prepared and stimulated with PPE for 72 h. Cytokines were
measured by ELISA. Data are presented as means 6 SD for each group of mice. N: naı ¨ve mice, S: sensitized mice. ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0031967.g003
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31967was transferrable by isolated regulatory T cells from spleen of mice
[28].
Thus, we have shown here that EPIT using ViaskinH loaded
with 100 mg of PPE and applied weekly over 48 h for 8
consecutive weeks before sustained oral exposure to peanuts in
sensitized mice prevents the development of any digestive injuries.
This contrasts with the observations of Akei et al. [29] whose
studies suggest that epicutaneous exposure to allergens could
prime for digestive injuries, especially EoE, via a Th2-dependant
mechanism. Moreover, in the present study, peripheral sIgE and
sIgG2a, monitored every two weeks, showed with EPIT a rapid
increase of sIgG2a and a more gradual, slight decrease of sIgE.
sIgG1 remained unchanged. A previous immunotherapy study in
peanut-sensitized mice [30], showed a similar reduction of peanut-
specific IgE levels throughout the treatment, accompanied by a
persistent elevation in sIgG2a, a subclass of IgG which acts as a
blocking antibody and interferes with mast cell degranulation via
FceRI ligation and antigen interception [31]. Thus, in addition to
sustained reduction of peanut-specific IgE, increased peanut-
specific IgG2a may contribute to the benefits of treatment with
EPIT. At the cellular level, we also found that EPIT reduced the
splenocyte secretion of IL-4, IL-5, IL-10, and IL-13 produced by
CD4
+ Th2-cells, which play a central role in the pathogenesis of
allergic disorders [32]. In contrast, the Th1 cytokine IFN-c was
not modulated by EPIT, suggesting that the treatment established
a more balanced Th1/Th2 ratio. Epicutaneous application of
allergens onto intact skin of sensitized mice leads to its transport via
dendritic cells to the draining lymph node. The migration of
allergen-loaded professional APC regulated by a complex
interplay of soluble and membrane-bound signals is likely to
promote the specific regulatory T cell response not only at the
draining lymph node but [33], but also at the systemic level, thus
reaching the gut immune system [34].
In conclusion, we developed an original model of sustained oral
exposure to peanuts resulting in EoE combined with villus sub-
atrophy in sensitized animals. This model was then used to assess
Figure 4. Effect of EPIT on the induction of peanut-induced allergic esophagus inflammation established by histological and RT-
qPCR analyses Microscopic analysis of eosinophils in the esophagus at 406 (A–C) and 1006 high-powered fields (D–F). Most
eosinophils (arrows) are located in the lamina propia, submucosa, and epithelial layer of the sham group and to a lesser extent of the EPIT group. A
difference in the thickness of epithelium is observed between naive/EPIT and sham. Analysis of (G) chorion inflammation, (H) acanthosis, (I)
measurement of eosinophil infiltration in the esophagus and in 406high-powered fields. Grading for chorion inflammation is as follows: 0=nothing,
1=slight diffuse infiltration, 2=perivascular area. Grading for acanthosis is as follows: 0=nothing, 1=layer with more than 4 cells, 2=layer with more
than 6 cells. The epithelium thickness was expressed as mean (mm) 6SD. For eosinophils, the results are expressed as number of eosinophils per mm
2
(means 6 SD). Cytokine mRNA from esophagus segments collected 24 h after stopping peanut diet was assayed by RT-qPCR. Results are presented
as mRNA expression of naive, Sham or EPIT animals. The relative levels of gene expression were calculated by reference to the mRNA levels of SDHA
and b-actin in each sample. (J) eotaxin, (K) IL-5, (L) IL-13, (M) Foxp3, (N)GATA-3, (O) Tbet. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0031967.g004
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31967Figure 5. Effect of EPIT on the induction of peanut-induced allergic enteropathy. (A–F) Jejunum segments collected and analyzed by
microscopy after HES coloration (640). Upper layer: villous atrophia could be observed in the sham group. Lower layer: inflammatory infiltration,
particularly of eosinophils is shown. (G) Measurement of the ratio of villous height by crypt depth for each group of 10 mice under 106high-powered
fields. Results are expressed as means 6 SD. ns: non significant, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0031967.g005
Figure 6. Effect of EPIT on systemic response induced in mice after oral sensitization. (A) Quantity of specific IgE expressed in mg.ml
21 for
each group. (B) Quantity of specific IgG2a expressed in mg.ml
21 for each group. (C) Determination of the IgG1/IgG2a ratio expressed for each group.
D44 (week 6) concords with the end of sensitization and from D44 to D99 (weeks 7 to 14) with the immunotherapy. Data are expressed as means 6
SD for each group of 10 mice. (D–H) Measurement of Th2 cytokine levels (IL-4, IL-5, IL-10, IL-13) and IFN-c secretion by splenocytes collected from
each group of mice (EPIT, Sham, and naı ¨ve) immediately after sacrifice. Splenocytes were prepared and stimulated with PPE for 72 h. Cytokines were
measured by ELISA. Data are presented as means 6 SD for each group of 10 mice. ns: non significant, * p,0.05, ** p,0.01 and *** p,0.001.
doi:10.1371/journal.pone.0031967.g006
EPIT in a Mouse Model of Esophago-Gastro-Enteropathy
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31967the efficacy of EPIT, which rendered peanut-sensitized mice
almost insensitive to the peanut regimen. This study may open the
way to a specific immunotherapy approach in allergy-induced
diseases especially EoE and enteropathy. Further studies will be
mandatory to confirm that EPIT is the most effective method.
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